Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
We've added below videos to our Videos repository.
The video is titled
Daratumumab vs Active Monitoring for High-Risk Smoldering Multiple Myeloma by Samer Al Hadidi, M.D., M.S. (CRDSA), FACP from Associate Professor Myeloma Center, Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock, AR, and it's been added/updated in Multiple Myeloma Category
How I Manage POEMS Syndrome by David Dingli MD PhD from Professor of Medicine Mayo Clinic Rochester, MN, and it's been added/updated in Multiple Myeloma Category
Here are the latest posts last week:
Blogs :
Dr. Joseph discusses the effects of resistance training on fatigue and pain in multiple myeloma.
Dr. Spencer discusses rationale for evaluating novel CAR T-cell product in pancreatic cancer.
Afami-Cel’s potential impact on standard care for R/R cases.
Dr. Albigès on survival outcomes with Cabozantinib, Nivolumab, and Ipilimumab in RCC.
Drs. Al Malki and Auletta discuss PTCy GVHD prophylaxis in HLA-UUMD patients.
Dr. Meric-Bernstam on efficacy and safety of Dato-DXd in urothelial cancer.
Dr. Pothuri discusses the current treatment paradigm in endometrial cancer.
Dr. Shah discusses efficacy data for Zamto-Cel in R/R DLBCL.
Personalized Myelofibrosis Therapy: Key Clinical Trial Insights and Findings
Dr. Gupta on updated Enfortumab Vedotin-Pembrolizumab data in urothelial cancer.
Dr. Merseburger on real-world outcomes of Axitinib-Avelumab in RCC.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
We've added below videos to our Videos repository.
The video is titled
Daratumumab vs Active Monitoring for High-Risk Smoldering Multiple Myeloma by Samer Al Hadidi, M.D., M.S. (CRDSA), FACP from Associate Professor Myeloma Center, Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock, AR, and it's been added/updated in Multiple Myeloma Category
How I Manage POEMS Syndrome by David Dingli MD PhD from Professor of Medicine Mayo Clinic Rochester, MN, and it's been added/updated in Multiple Myeloma Category
Here are the latest posts last week:
Blogs :
Dr. Joseph discusses the effects of resistance training on fatigue and pain in multiple myeloma.
Dr. Spencer discusses rationale for evaluating novel CAR T-cell product in pancreatic cancer.
Afami-Cel’s potential impact on standard care for R/R cases.
Dr. Albigès on survival outcomes with Cabozantinib, Nivolumab, and Ipilimumab in RCC.
Drs. Al Malki and Auletta discuss PTCy GVHD prophylaxis in HLA-UUMD patients.
Dr. Meric-Bernstam on efficacy and safety of Dato-DXd in urothelial cancer.
Dr. Pothuri discusses the current treatment paradigm in endometrial cancer.
Dr. Shah discusses efficacy data for Zamto-Cel in R/R DLBCL.
Personalized Myelofibrosis Therapy: Key Clinical Trial Insights and Findings
Dr. Gupta on updated Enfortumab Vedotin-Pembrolizumab data in urothelial cancer.
Dr. Merseburger on real-world outcomes of Axitinib-Avelumab in RCC.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
